据Louisvillen Business首次报导，当地公司Neuronetrix研发的产品COGNISION系统获得美国FDA上市许可。COGNISION系统通过检测脑电波来诊断某些神经类疾病。它获取定量脑电图（qEEG），并通过公司在线服务器对事件相关电位（ERP）数据处理，从而对疾病进行诊断。

该系统检测结果与前期研究结果进行对比，并根据它们的特征脑电波类型对患者分类诊断。这项技术将有望成为诊断各种神经系统疾病的一种有用的新方法。

产品特点：

• 无线，电池供电，能在办公室环境使用
• 友好的头盔设计，合适不同个体
• 校准插入式耳机，确保听觉刺激一致
• Active电极，信噪比高，伪差少
• 方便Hydro-Dot®传感器，易使用，皮肤接触阻抗低

英文原文

Louisville Business First is reporting that Neuronetrix, a local firm, landed FDA clearance for its COGNISION system. It's used to detect brainwave markers that point to the existence of certain neurological diseases, by producing quantitative electroencephalography (qEEG) and event-related potential (ERP) data processed by the company's online server.

Results from the system are compared to data from previous studies of qEEG/ERP to classify patients based on their characteristic brainwave patterns. The hope is that this technology will serve as a useful modality for diagnosing a variety of neurological conditions.

Feature from the product page:

• Wireless, battery-powered system for use in an office environment
• Subject-friendly headset fits a large range of head sizes
• Calibrated insert earphones ensure consistent auditory stimuli
• Active electrodes provide high SNR and fewer artifacts
• Integrated action buttons for subject responses
• Convenient Hydro-Dot® Biosensors are easy to apply and deliver very low skin contact impedance